Your browser doesn't support javascript.
loading
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.
Vaz-Luis, I; Masiero, M; Cavaletti, G; Cervantes, A; Chlebowski, R T; Curigliano, G; Felip, E; Ferreira, A R; Ganz, P A; Hegarty, J; Jeon, J; Johansen, C; Joly, F; Jordan, K; Koczwara, B; Lagergren, P; Lambertini, M; Lenihan, D; Linardou, H; Loprinzi, C; Partridge, A H; Rauh, S; Steindorf, K; van der Graaf, W; van de Poll-Franse, L; Pentheroudakis, G; Peters, S; Pravettoni, G.
Afiliação
  • Vaz-Luis I; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy-Cancer Campus, Villejuif; UMR 981, Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy-Cancer Campus, Villejuif, France. Electronic address: Ines-Maria.Vaz-Duarte-Luis@gustaveroussy.fr.
  • Masiero M; Department of Oncology and Hemato-Oncology, University of Milano, Milan; Applied Research Division for Cognitive and Psychological Science, Istituto Europeo di Oncologia, Milan.
  • Cavaletti G; Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Cervantes A; Department of Medical Oncology, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Chlebowski RT; The Lundquist Institute, Torrance, USA.
  • Curigliano G; Department of Oncology and Hemato-Oncology, University of Milano, Milan; Division of Early Drug Development, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.
  • Felip E; Vall d'Hebron University Hospital, Barcelona, Spain.
  • Ferreira AR; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon; Catolica Medical School, Universidade Católica Portuguesa, Lisbon, Portugal.
  • Ganz PA; UCLA Jonsson Comprehensive Cancer Center and UCLA Fielding School of Public Health, Los Angeles, USA.
  • Hegarty J; School of Nursing and Midwifery, University College Cork, Cork, Ireland.
  • Jeon J; Exercise Medicine Center for Cancer and Diabetes Patients (ICONS), Department of Sport Industry, Cancer Prevention Center, Yonsei Cancer Center, Shinchon Severance Hospital, Yonsei University College of Medicine, Yonsei University, Seoul, Korea.
  • Johansen C; Centre for Cancer Late Effect Research (CASTLE), Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Joly F; Department of Medical Oncology, Centre François Baclesse, U1086 Anticipe, Unicaen Normandy Universtity, Caen, France.
  • Jordan K; Department for Hematology, Oncology and Palliative Medicine, Ernst von Bergmann Hospital, Potsdam; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
  • Koczwara B; Flinders Medical Centre and Flinders University, Adelaide, Australia.
  • Lagergren P; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Lambertini M; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.
  • Lenihan D; International Cardio-Oncology Society, Tampa, USA.
  • Linardou H; Fourth Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece.
  • Loprinzi C; Mayo Clinic, Rochester.
  • Partridge AH; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Rauh S; Department of Medical Oncology, Centre Hospitalier Emile Mayrisch, Esch, Luxembourg.
  • Steindorf K; Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • van der Graaf W; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam; Department of Medical Oncology, Erasmus MC Cancer institute, Erasmus University Medical Center, Rotterdam.
  • van de Poll-Franse L; Division of Psychosocial Research & Epidemiology, Department of Psycological Research, The Netherlands Cancer Institute, Amsterdam; Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht; CoRPS-Center of Research on Psychology in Somatic diseases,
  • Pentheroudakis G; European Society for Medical Oncology (ESMO), Lugano, Switzerland.
  • Peters S; European Society for Medical Oncology (ESMO), Lugano, Switzerland.
  • Pravettoni G; Department of Oncology and Hemato-Oncology, University of Milano, Milan; Applied Research Division for Cognitive and Psychological Science, Istituto Europeo di Oncologia, Milan.
Ann Oncol ; 33(11): 1119-1133, 2022 11.
Article em En | MEDLINE | ID: mdl-35963481
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article